3,4-D
- CAS NO.：588-22-7
- Empirical Formula: C8H6Cl2O3
- Molecular Weight: 221.04
- MDL number: MFCD00004303
- EINECS: 209-612-4
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-01-13 11:22:52
What is 3,4-D?
The Uses of 3,4-D
3,4-Dichlorophenoxyacetic acid was used in the synthesis of layered organic-inorganic nanohybrid material, zinc-aluminum-3,4-dicholorophenoxyacetate.
What are the applications of Application
3,4-Dichlorophenoxyacetic acid is a synthesis reagent
Definition
ChEBI: A chlorophenoxyacetic acid that is phenoxyacetic acid in which the hydrogens at positions 3 and 4 of the phenyl group are replaced by chlorines.
General Description
3,4-Dichlorophenoxyacetic acid is a phenoxyacetic herbicide.
Properties of 3,4-D
| Melting point: | 138-140 °C(lit.) |
| Boiling point: | 316.96°C (rough estimate) |
| Density | 1.4564 (rough estimate) |
| refractive index | 1.5000 (estimate) |
| Flash point: | 2 °C |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| form | Crystalline Powder |
| pka | 2.99±0.10(Predicted) |
| color | White |
| Water Solubility | 457.6mg/L(25 ºC) |
Safety information for 3,4-D
| Signal word | Warning |
| Pictogram(s) |
 Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H315:Skin corrosion/irritation H317:Sensitisation, Skin H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
| Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P280:Wear protective gloves/protective clothing/eye protection/face protection. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for 3,4-D
New Products
Methyl N-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-N-nitroso-L-valinate Levofloxacin - Impurity B/ Levofloxacin Related Compound A Ivabradine R isomer Escitalopram - Impurity K Escitalopram Cyno dilol Impurity Paroxetine EP impurity I/Paroxetine Anhydrous EP Impurity I 2-Amino-5-Bromo-6-Chloropyridine 3-Amino-5-bromopicolinic acid 1-(7,8-Dinitro-4,5-dihydro-1H-1,5-methanobenzo[d]azepin-3(2H)-yl)-2,2,2-trifluoroethanone 2-Amino-3-Bromo-5-Cyanopyridine 2-Amino-3-Chloropyridine 2,5-Dibromo-3-MethylpyridineRelated products of tetrahydrofuran
You may like
-
3, 4-Dichlorophenoxyacetic acid CAS 588-22-7View Details
588-22-7 -
17471-10-2 Diphenhydramine EP impurity-A /Diphenhydramine Related Compound A NLT 95%View Details
17471-10-2 -
Dorzolamide Related Compound B/Dorzolamide EP Impurity B NLT 95%View Details
120279-90-5 -
76824-16-3 Famotidine - Impurity D NLT 95%View Details
76824-16-3 -
118-23-0 NLT 95%View Details
118-23-0 -
Miconazole EP Impurity F/ Miconazole USP Related Compound F 47447-55-2 NLT 95%View Details
47447-55-2 -
2407630-84-4 NLT 95%View Details
2407630-84-4 -
573704-41-3 NLT 95%View Details
573704-41-3
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.